Arkolith/Insider Trading/IMVT/Form 4

Fromkin Andrew J.

DirectorImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Dec 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$517K
Net Open-Market Flow
-$517K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2025Sell(S)19K$23.14$448K89K
Dec 1, 2025Sell(S)3K$23.95$69K86K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-25-000160) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML